TEVA: Dana dhuwit saben saham Teva Pharmaceutical Industries Ltd.

Innovative drugs and a debt reduction strategy are driving the growth of Teva Pharmaceutical Industries (TEVA). The current liquidity per share on the GURU.Markets base chart shows that the latest mark is 3.49. The holding's stability relies on its massive generic production scale, which allows it to mitigate market pricing pressure, while the development of biologics ensures the business's transition to a phase of profitable maturity.
Rincian metrik komprehensif lan analitis Teva Pharmaceutical Industries (TEVA)

This metric determines the volume of liquid assets per ordinary share, reflecting the business's actual financial coverage and its level of solvency. By analyzing the quarterly dynamics of cash per share, an investor can assess the capital management efficiency of Teva Pharmaceutical Industries (TEVA), where cost optimization through the outsourcing of generics production and logistics directly impacts the volume of free cash reserves.